NASDAQ:IPSC | Free Cash Flow | Century Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$25.26M$584,000.00-$25.85M
2025-12-31-$16.08M-$139,000.00-$16.22M
2025-03-31-$34.62M$475,000.00-$35.1M-45.84%
2024-12-31-$24.22M
2024-03-31-$30.25M$539,000.00-$30.79M
2023-12-31-$26.23M$980,000.00-$27.21M
2023-03-31-$29.22M$4.99M-$34.21M
2022-12-31-$22.91M$6.27M-$29.18M
2022-03-31$86.75M$4.07M$82.69M
2021-12-31-$24.35M$16.72M-$41.07M
2021-03-31-$22.18M$1.88M-$24.06M
2020-12-31-$13.22M$1.9M-$15.12M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$103.88M$848,000.00-$104.72M
2024-12-31-$110.14M$154,000.00-$110.29M
2023-12-31-$88.35M$13.74M-$102.08M
2022-12-31$14.05M$30.6M-$16.55M
2021-12-31-$89M$44.97M-$133.97M
2020-12-31-$41.27M$9.83M-$51.09M